Inhibitory effects of bee venom on mast cell-mediated allergic inflammatory responses

  • Authors:
    • Yun‑Mi Kang
    • Kyung‑Sook Chung
    • In‑Hoon Kook
    • Yoon‑Bum Kook
    • Hyunsu Bae
    • Minho Lee
    • Hyo‑Jin An
  • View Affiliations

  • Published online on: March 12, 2018     https://doi.org/10.3892/ijmm.2018.3558
  • Pages: 3717-3726
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Although bee venom (BV) is a toxin that causes bee stings to be painful, it has been widely used clinically for the treatment of certain immune‑associated diseases. BV has been used traditionally for the treatment of chronic inflammatory diseases. In this regard, the present study analyzed the effect of BV on the regulation of inflammatory mediator production by mast cells and their allergic inflammatory responses in an animal model. HMC‑1 cells were treated with BV prior to stimulation with phorbol‑12‑myristate 13‑acetate plus calcium ionophore A23187 (PMACI). The production of allergy‑associated pro‑inflammatory mediators was examined, and the underlying mechanisms were investigated. Furthermore, to investigate whether BV exhibits anti‑inflammatory effects associated with anti‑allergic effects in vivo, a compound 48/80‑induced anaphylaxis model was used. BV inhibited histamine release, mRNA expression and production of cytokines in the PMACI‑stimulated HMC‑1 cells. Furthermore, the inhibitory effects of BV on mitogen‑activated protein kinase (MAPK), MAPK kinase, signal transducer and activator of transcription 3 (STAT3) and Akt were demonstrated. The present study also investigated the ability of BV to inhibit compound 48/80‑induced systemic anaphylaxis in vivo. BV protected the mice against compound 48/80‑induced anaphylactic‑associated mortality. Furthermore, BV suppressed the mRNA expression levels of pro‑inflammatory cytokines, and suppressed the activation of MAPK and STAT3 in this model. These results provide novel insights into the possible role of BV as a modulator for mast cell‑mediated allergic inflammatory disorders.

References

1 

Hong MH, Kim JH, Bae H, Lee NY, Shin YC, Kim SH and Ko SG: Atractylodes japonica Koidzumi inhibits the production of proinflammatory cytokines through inhibition of the NF-κB/IκB signal pathway in HMC-1 human mast cells. Arch Pharm Res. 33:843–851. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Sohn Y, Han NY, Lee MJ, Cho HJ and Jung HS: [6]-Shogaol inhibits the production of proinflammatory cytokines via regulation of NF-κB and phosphorylation of JNK in HMC-1 cells. Immunopharmacol Immunotoxicol. 35:462–470. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Kim JY and Ro JY: Signal pathway of cytokines produced by reactive oxygen species generated from phorbol myristate acetate-stimulated HMC-1 cells. Scand J Immunol. 62:25–35. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Jeong HJ, Hong SH, Park RK, An NH and Kim HM: Ethanol induces the production of cytokines via the Ca2+, MAP kinase, HIF-1α, and NF-κB pathway. Life Sci. 77:2179–2192. 2005. View Article : Google Scholar : PubMed/NCBI

5 

Ko YJ, Kim HH, Kim EJ, Katakura Y, Lee WS, Kim GS and Ryu CH: Piceatannol inhibits mast cell-mediated allergic inflammation. Int J Mol Med. 31:951–958. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Jeon YD, Kee JY, Kim DS, Han YH, Kim SH, Kim SJ, Um JY and Hong SH: Effects of Ixeris dentata water extract and caffeic acid on allergic inflammation in vivo and in vitro. BMC Complement Altern Med. 15:1962015. View Article : Google Scholar : PubMed/NCBI

7 

Ichijo H: From receptors to stress-activated MAP kinases. Oncogene. 18:6087–6093. 1999. View Article : Google Scholar : PubMed/NCBI

8 

Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, et al: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 273:18623–18632. 1998. View Article : Google Scholar : PubMed/NCBI

9 

Zou J, Wang R, Li R, Kong Y, Wang J, Ning X, Zhang L, Wang S, Hu X and Bao Z: The genome-wide identification of mitogen-activated protein kinase kinase (MKK) genes in Yesso scallop Patinopecten yessoensis and their expression responses to bacteria challenges. Fish Shellfish Immunol. 45:901–911. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Glosson NL, Bruns HA and Kaplan MH: Wheezing and itching: The requirement for STAT proteins in allergic inflammation. JAKSTAT. 1:3–12. 2012.PubMed/NCBI

11 

Samavati L, Rastogi R, Du W, Hüttemann M, Fite A and Franchi L: STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol. 46:1867–1877. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Michaud-Levesque J, Bousquet-Gagnon N and Béliveau R: Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration. Exp Cell Res. 318:925–935. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Zolfagharian H, Mohajeri M and Babaie M: Honey bee venom (Apis mellifera) contains anticoagulation factors and increases the blood-clotting time. J Pharmacopuncture. 18:7–11. 2015. View Article : Google Scholar

14 

Ali MAA-SM: Studies on bee venom and its medical uses. Int J Adv Res Technol. 1:69–83. 2012.

15 

Hwang DS, Kim SK and Bae H: Therapeutic effects of Bee Venom on immunological and neurological diseases. Toxins. 7:2413–2421. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Kim WH, An HJ, Kim JY, Gwon MG, Gu H, Park JB, Sung WJ, Kwon YC, Park KD, Han SM and Park KK: Bee venom inhibits porphyromonas gingivalis lipopolysaccharides-induced pro-inflammatory cytokines through suppression of NF-κB and AP-1 signaling pathways. Molecules. 21:E15082016. View Article : Google Scholar

17 

Zolfagharian H, Mohajeri M and Babaie M: Bee venom (Apis Mellifera) an effective potential alternative to gentamicin for specific bacteria strains: Bee venom an effective potential for bacteria. J Pharmacopuncture. 19:225–230. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Nipate SS, Hurali PB and Ghaisas MM: Evaluation of anti-inflammatory, anti-nociceptive, and anti-arthritic activities of Indian Apis dorsata bee venom in experimental animals: Biochemical, histological, and radiological assessment. Immunopharmacol Immunotoxicol. 37:171–184. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Kim KH, Kum YS, Park YY, Park JH, Kim SJ, Lee WR, Lee KG, Han SM and Park KK: The protective effect of bee venom against ethanol-induced hepatic injury via regulation of the mitochondria-related apoptotic pathway. Basic Clin Pharmacol Toxicol. 107:619–624. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Russell PJ, Hewish D, Carter T, Sterling-Levis K, Ow K, Hattarki M, Doughty L, Guthrie R, Shapira D, Molloy PL, et al: Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: In vitro and in vivo studies. Cancer Immunol Immunother. 53:411–421. 2004. View Article : Google Scholar : PubMed/NCBI

21 

Son DJ, Lee JW, Lee YH, Song HS, Lee CK and Hong JT: Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 115:246–270. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Park HJ, Lee SH, Son DJ, Oh KW, Kim KH, Song HS, Kim GJ, Oh GT, Yoon DY and Hong JT: Antiarthritic effect of bee venom: Inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 50:3504–3515. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Shin SH, Kim YH, Kim JK and Park KK: Anti-allergic effect of bee venom in an allergic rhinitis mouse model. Biol Pharm Bull. 37:1295–1300. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Huh JE, Baek YH, Lee MH, Choi DY, Park DS and Lee JD: Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice. Cancer Lett. 292:98–110. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Choi MS, Park S, Choi T, Lee G, Haam KK, Hong MC, Min BI and Bae H: Bee venom ameliorates ovalbumin induced allergic asthma via modulating CD4+CD25+ regulatory T cells in mice. Cytokine. 61:256–265. 2013. View Article : Google Scholar

26 

An HJ, Lee WR, Kim KH, Kim JY, Lee SJ, Han SM, Lee KG, Lee CK and Park KK: Inhibitory effects of bee venom on Propionibacterium acnes-induced inflammatory skin disease in an animal model. Int J Mol Med. 34:1341–1348. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

28 

Choi YH, Chai OH, Han EH, Choi SY, Kim HT and Song CH: Lipoic acid suppresses compound 48/80-induced anaphy-laxis-like reaction. Anat Cell Biol. 43:317–324. 2010. View Article : Google Scholar

29 

Chai OH, Shon DH, Han EH, Kim HT and Song CH: Effects of Anemarrhena asphodeloides on IgE-mediated passive cutaneous anaphylaxis, compound 48/80-induced systemic anaphylaxis and mast cell activation. Exp Toxicol Pathol. 65:419–426. 2013. View Article : Google Scholar

30 

Cho MS, Park WS, Jung WK, Qian ZJ, Lee DS, Choi JS, Lee DY, Park SG, Seo SK, Kim HJ, et al: Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cells. Pharm Biol. 52:926–932. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Li L, Jin G, Jiang J, Zheng M, Jin Y, Lin Z, Li G, Choi Y and Yan G: Cornuside inhibits mast cell-mediated allergic response by down-regulating MAPK and NF-κB signaling pathways. Biochem Biophys Res Commun. 473:408–414. 2016. View Article : Google Scholar : PubMed/NCBI

32 

Dérijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ and Davis RJ: Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:682–685. 1995. View Article : Google Scholar : PubMed/NCBI

33 

Chae HS, Kim YM and Chin YW: Atractylodin inhibits interleukin-6 by blocking NPM-ALK activation and MAPKs in HMC-1. Molecules. 21:E11692016. View Article : Google Scholar : PubMed/NCBI

34 

Granato M, Rizzello C, Gilardini Montani MS, Cuomo L, Vitillo M, Santarelli R, Gonnella R, D'Orazi G, Faggioni A and Cirone M: Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways. J Nutr Biochem. 41:124–136. 2017. View Article : Google Scholar : PubMed/NCBI

35 

Choi YH, Yan GH, Chai OH, Lim JM, Sung SY, Zhang X, Kim JH, Choi SH, Lee MS, Han EH, et al: Inhibition of anaphylaxis-like reaction and mast cell activation by water extract from the fruiting body of Phellinus linteus. Biol Pharm Bull. 29:1360–1365. 2006. View Article : Google Scholar : PubMed/NCBI

36 

Li GZ, Chai OH, Lee MS, Han EH, Kim HT and Song CH: Inhibitory effects of Houttuynia cordata water extracts on anaphylactic reaction and mast cell activation. Biol Pharm Bull. 28:1864–1868. 2005. View Article : Google Scholar : PubMed/NCBI

37 

Minai-Fleminger Y and Levi-Schaffer F: Mast cells and eosinophils: The two key effector cells in allergic inflammation. Inflamm Res. 58:631–638. 2009. View Article : Google Scholar : PubMed/NCBI

38 

Zampeli E and Tiligada E: The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol. 157:24–33. 2009. View Article : Google Scholar : PubMed/NCBI

39 

Kim MH, Seo JH, Kim HM and Jeong HJ: Zinc oxide nanoparticles, a novel candidate for the treatment of allergic inflammatory diseases. Eur J Pharmacol. 738:31–39. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Foster JR: The functions of cytokines and their uses in toxicology. Int J Exp Pathol. 82:171–192. 2001. View Article : Google Scholar : PubMed/NCBI

41 

Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A and Tuomanen E: The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med. 171:439–448. 1990. View Article : Google Scholar : PubMed/NCBI

42 

Ye J, Piao H, Jiang J, Jin G, Zheng M, Yang J, Jin X, Sun T, Choi YH, Li L and Yan G: Polydatin inhibits mast cell-mediated allergic inflammation by targeting I3K/Akt, MAPK, NF-κB and Nrf2/HO-1 pathways. Sci Rep. 7:118952017. View Article : Google Scholar

43 

Nam SY, Kim HY, Yoou MS, Kim AH, Park BJ, Jeong HJ and Kim HM: Anti-inflammatory effects of isoacteoside from Abeliophyllum distichum. Immunopharmacol Immunotoxicol. 37:258–264. 2015. View Article : Google Scholar : PubMed/NCBI

44 

Song Q, Li D, Dai Y, Liu S, Huang L, Hong Y, Zhang H and Song F: Characterization, expression patterns and functional analysis of the MAPK and MAPKK genes in watermelon (Citrullus lanatus). BMC Plant Biol. 15:2982015. View Article : Google Scholar : PubMed/NCBI

45 

Barnes PJ: Transcription factors in airway diseases. Lab Invest. 86:867–872. 2006. View Article : Google Scholar : PubMed/NCBI

46 

Siegel AM, Stone KD, Cruse G, Lawrence MG, Olivera A, Jung MY, Barber JS, Freeman AF, Holland SM, O'Brien M, et al: Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol. 132:1388–1396. 2013. View Article : Google Scholar : PubMed/NCBI

47 

Ivashkiv LB: Jak-STAT signaling pathways in cells of the immune system. Rev Immunogenet. 2:220–230. 2000.

48 

Schuringa JJ, Jonk LJ, Dokter WH, Vellenga E and Kruijer W: Interleukin-6-induced STAT3 transactivation and Ser727 phos-phorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components. Biochem J. 347:89–96. 2000. View Article : Google Scholar

49 

Decker T and Kovarik P: Serine phosphorylation of STATs. Oncogene. 19:2628–2637. 2000. View Article : Google Scholar : PubMed/NCBI

50 

Krishnamurthy P and Kaplan MH: STAT6 and PARP family members in the development of T cell-dependent allergic inflammation. Immune Netw. 16:201–210. 2016. View Article : Google Scholar : PubMed/NCBI

51 

Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W and Haegeman G: p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem. 273:3285–3290. 1998. View Article : Google Scholar : PubMed/NCBI

52 

Jang HS, Kim SK, Han JB, Ahn HJ, Bae H and Min BI: Effects of bee venom on the pro-inflammatory responses in RAW264.7 macrophage cell line. J Ethnopharmacol. 99:157–160. 2005. View Article : Google Scholar : PubMed/NCBI

53 

Hartman DA, Tomchek LA, Lugay JR, Lewin AC, Chau TT and Carlson RP: Comparison of antiinflammatory and antiallergic drugs in the melittin- and D49 PLA2-induced mouse paw edema models. Agents Actions. 34:84–88. 1991. View Article : Google Scholar : PubMed/NCBI

54 

Lariviere WR and Melzack R: The bee venom test: A new tonic-pain test. Pain. 66:271–277. 1996. View Article : Google Scholar : PubMed/NCBI

55 

Chung KS, An HJ, Cheon SY, Kwon KR and Lee KH: Bee venom suppresses testosterone-induced benign prostatic hyperplasia by regulating the inflammatory response and apoptosis. Exp Biol Med. 240:1656–1663. 2015. View Article : Google Scholar

Related Articles

Journal Cover

June 2018
Volume 41 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Kang, Y., Chung, K., Kook, I., Kook, Y., Bae, H., Lee, M., & An, H. (2018). Inhibitory effects of bee venom on mast cell-mediated allergic inflammatory responses. International Journal of Molecular Medicine, 41, 3717-3726. https://doi.org/10.3892/ijmm.2018.3558
MLA
Kang, Y., Chung, K., Kook, I., Kook, Y., Bae, H., Lee, M., An, H."Inhibitory effects of bee venom on mast cell-mediated allergic inflammatory responses". International Journal of Molecular Medicine 41.6 (2018): 3717-3726.
Chicago
Kang, Y., Chung, K., Kook, I., Kook, Y., Bae, H., Lee, M., An, H."Inhibitory effects of bee venom on mast cell-mediated allergic inflammatory responses". International Journal of Molecular Medicine 41, no. 6 (2018): 3717-3726. https://doi.org/10.3892/ijmm.2018.3558